Viewing data from:

DIVALPROEX SODIUM

ANDA

DIVALPROEX SODIUM | A077567 | MYLAN PHARMACEUTICALS INC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: DEPAKOTE ER(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 6 NDCs

Highest NADAC/Unit

$0.1838

per ea

Lowest NADAC/Unit

$0.1383

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00378047301DIVALPROEX SOD ER 500 MG TAB	$0.1838	EA	Generic	—	2026-06-17
00378047305DIVALPROEX SOD ER 500 MG TAB	$0.1838	EA	Generic	—	2026-06-17
51079076708DIVALPROEX SOD ER 500 MG TAB	$0.1838	EA	Generic	—	2026-06-17
00378047201DIVALPROEX SOD ER 250 MG TAB	$0.1383	EA	Generic	—	2026-06-17
00378047205DIVALPROEX SOD ER 250 MG TAB	$0.1383	EA	Generic	—	2026-06-17
51079076608DIVALPROEX SOD ER 250 MG TAB	$0.1383	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 6 NDCs (6 FSS)

Lowest Price

$21.10

Highest Price

$212.44

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00378-0472-01DIVALPROEX NA 250MG TAB,SA	$21.10	FSS	Mylan Pharmaceuticals, Inc.	12/31/2027
00378-0472-05DIVALPROEX NA 250MG TAB,SA	$108.83	FSS	Mylan Pharmaceuticals, Inc.	12/31/2027
00378-0473-01DIVALPROEX NA 500MG TAB,SA	$42.49	FSS	Mylan Pharmaceuticals, Inc.	12/31/2027
00378-0473-05DIVALPROEX NA 500MG TAB,SA	$212.44	FSS	Mylan Pharmaceuticals, Inc.	12/31/2027
51079-0766-08DIVALPROEX SODIUM 250MG ER TAB,10X30	$78.86	FSS	Mylan Institutional, Inc.	09/29/2026
51079-0767-08DIVALPROEX SODIUM 500MG ER TAB	$132.53	FSS	Mylan Institutional, Inc.	09/29/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain16 active DMFs5 inactive

14 active API suppliers hold Drug Master Files for this ingredient.

PCASDIVALPROEX SODIUM

DMF 146461999

KATWIJK CHEMIE BVDIVALPROEX SODIUM

DMF 163122002

WOCKHARDT LTDDIVALPROEX SODIUM

DMF 174692004

SCI PHARMTECH INCDIVALPROEX SODIUM

DMF 182852005

SUVEN LIFE SCIENCES LTDDIVALPROEX SODIUM

DMF 192662006

DR REDDYS LABORATORIES LTDDIVALPROEX SODIUM USP

DMF 198712006

SUN PHARMACEUTICAL INDUSTRIES LTDDIVALPROEX SODIUM USP

DMF 198842006

ANJAN DRUG PRIVATE LTDDIVALPROEX SODIUM USP

DMF 200362006

ORBION PHARMACEUTICALS PRIVATE LTDDIVALPROEX SODIUM

DMF 202062007

HARMAN FINOCHEM LTDDIVALPROEX SODIUM USP

DMF 215322008

RAKS PHARMA PVT LTDDIVALPROEX SODIUM USP

DMF 239152010

APITORIA PHARMA PRIVATE LTDDIVALPROEX SODIUM USP

DMF 290972015

HETERO DRUGS LTDDIVALPROEX SODIUM

DMF 314372018

MAITHRI DRUGS PRIVATE LTDDIVALPROEX SODIUM USP

DMF 344402019

SUN PHARMACEUTICAL INDUSTRIES LTDDIVALPROEX SODIUM USP (PROCESS II)

DMF 389112023

APITORIA PHARMA PRIVATE LTDDIVALPROEX SODIUM USP (PROCESS-II)

DMF 418712026

SELOC FRNCEInactiveDIVALPROEX SODIUM

DMF 75531988

CILAG AGInactiveDIVALPROEX SODIUM

DMF 162242002

PROCOS SPAInactiveDIVALPROEX SODIUM

DMF 173492004

CHENG FONG CHEMICAL CO LTDInactiveDIVALPROEX SODIUM

DMF 180642005

GENESEN LABS LTDInactiveDIVALPROEX SODIUM

DMF 213412007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Feb 3, 2009	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — EQ 250MG VALPROIC ACID

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Jan 29, 2009

No patent or exclusivity listings for this strength.

#002 — EQ 500MG VALPROIC ACID

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Jan 29, 2009